Health Service Medical Supplies (Costs) Bill

commons reason

[The page and line references are to HL Bill 81, the bill as first printed for the Lords.]

LORDS AMENDMENT 3

Before Clause 1

3

Insert the following new Clause—

 

“Duty to have regard to the life sciences sector and access to new medicines and

 

treatments

 

In discharging, through the provisions established or amended by this Act,

 

its responsibility to secure best value for the National Health Service in

 

purchasing medicines and medical supplies, the Government must have

 

full regard to the need to—

 

(a)    

promote and support a growing life sciences sector within the

 

United Kingdom economy; and

 

(b)    

ensure that patients have rapid clinical access to new clinically

 

effective and cost-effective medicines and treatments approved by

 

the National Institute for Health and Care Excellence through their

 

technology appraisal process.”

 

COMMONS REASON

 

The Commons disagree to Lords Amendment 3 for the following reason—

3A

Because it would not always be appropriate to use the powers conferred on the Secretary of

 

State to control the price of medicines and other medical supplies to promote and support

 

the growth of the life sciences sector, and those powers cannot be exercised to ensure that

 

patients have access to medicines and treatments.

 
 
HL Bill 11356/2

 
 

 

COMMONS REASON

 

16 March 2017

 
 

© Parliamentary copyright House of Lords


PUBLISHED BY AUTHORITY OF THE HOUSE OF LORDS

 
HL Bill 11356/2

 

 

Revised 17 March 2017